MicroBiome Restore is a general microbiome-support supplement and is not a GLP-1 medication, weight-loss product, or a substitute for prescribed treatment
GLP-1 medications are known as subcutaneous injections, which means they must be injected under the skin and into the fatty layer just below the surface
Last reviewed: June 19, 2026 Last updated: June 19, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
These combined effects may explain why retatrutide has produced significant weight loss in clinical trials
The preclinical side effect profile is favorable over 4 weeks: no pathological cardiac hypertrophy (some ERRalpha myocardial effects are physiological, dose is calibrated to remain in the adaptive range), no hepatic toxicity, no mitogenic signal at tested doses
Scrutinize wagering requirements, eligible games, contribution percentages, and expiration dates